Release Date: 24/10/18 09:28 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 508.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%